ABOUT THIS STUDY
Patients must meet all of the following inclusion criteria to be eligible for inclusion in the study:
1. Patients diagnosed as relapsed or refractory B-cell precursor lymphoblastic leukemia (ALL).
2. Evidence of a personally signed and dated informed consent document indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study.
Patients meeting any of the following criteria will not be included in the study:
1. Any patients who does not agree that Pfizer and companies working with Pfizer use
2. Patients to whom BESPONSA® is contraindicated as per the local labeling.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.